Themodest differences in antigen-specific CD8+ T cell responsescould be a result of modification of the lysine in SIINFEKL duringthe thiolation process, such that the antigen delivered is slightlydifferent from what is present on the cancer cells. The gene discussed is CD8A; the disease is cancer.